Swarthmore, PA, United States of America

Steven P Seitz

USPTO Granted Patents = 31 

 

Average Co-Inventor Count = 5.4

ph-index = 6

Forward Citations = 106(Granted Patents)


Location History:

  • Swarthmore, DE (US) (1994)
  • Swarthmore, PA (US) (1995 - 2024)

Company Filing History:


Years Active: 1994-2025

Loading Chart...
Loading Chart...
31 patents (USPTO):Explore Patents

Title: Steven P Seitz: Innovator in Medical Patents

Introduction: Steven P Seitz is a renowned inventor based in Swarthmore, PA, whose contributions to the field of pharmaceuticals are significant. With a remarkable portfolio of 28 patents, he has a proven track record of creating innovative solutions for treating various medical conditions, particularly proliferative disorders.

Latest Patents: Among his latest inventions are two notable patents: the first focuses on NLRP3 modulators, providing compounds that serve as potential medicaments for the treatment of proliferative disorders, including cancer. The second invention involves uracil derivatives as Mer-Axl inhibitors, which may be utilized in pharmaceutical compositions and methods to address cancers and disorders characterized by dysregulated apoptosis.

Career Highlights: Steven's career has seen impactful roles at prestigious companies, including Bristol-Myers Squibb Company and the DuPont Merck Pharmaceutical Company. His work at these institutions has facilitated the development of groundbreaking treatments and reinforced his status as a key figure in pharmaceutical innovation.

Collaborations: Throughout his career, Steven has collaborated with esteemed colleagues such as Jay A Markwalder and James Aaron Balog. These collaborations have fostered an environment of creativity and invention, allowing for the exploration of new therapeutic avenues in medicine.

Conclusion: Steven P Seitz is an inventive force in the pharmaceutical industry, with a strong emphasis on developing effective treatments for serious health conditions. His extensive patent portfolio and collaborative efforts demonstrate his commitment to innovation and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…